Antimicrobial resistance: global concern and the critical need for new antibiotics-Reference-Cited by-同舟云学术

Antimicrobial resistance: global concern and the critical need for new antibiotics

Published:2023-03-31 Issue: Volume: Page:1-3
ISSN:2582-8789
Container-title:The Applied Biology & Chemistry Journal
language:en
Short-container-title:TABCJ

Author:

Bhaskar Pranav¹^ORCID,Sahu Bijayani²^ORCID

Affiliation:

1. Braj Mohan Jha Science Research & Innovation Foundation, Chandigarh, India

2. School of Medicine & Health Sciences, University of North Dakota, Grand Forks, ND, USA

Abstract

Antimicrobial resistance (AMR) is a manifestation of evolution in real-time in response to chemical warfare against bacteria through the medicinal and non-therapeutic use of antimicrobial agents. Antibiotic resistance, which is a result of fast genetic evolution in bacteria, not only contributes to worldwide disease outbreaks but also reduces people's ability to effectively control significant human illnesses. Since sulfonamide and penicillin were first used in clinical settings in the 1930s and 1940s, respectively, many have believed that antibiotics are completely effective against infectious infections. However, due to the extensive use of antibiotics, a significant public health issue known as antibiotic resistance is currently evident.

Publisher

The Applied Biology & Chemistry Journal

Subject

General Medicine

Reference22 articles.

1. [1] Bhullar K, Waglechner N, Pawlowski A, Koteva K, Banks ED, Johnston MD, et al. Antibiotic resistance is prevalent in an isolated cave microbiome. PLoS One 2012; 7:e34953; http://dx.doi.org/10.1371/journal.pone.0034953; PMID: 22509370

2. [2] Livermore DM, Mushtaq S, Barker K, Hope R, Warner M, Woodford N. Characterization of β-lactamase and porin mutants of Enterobacteriaceae selected with ceftaroline + avibactam (NXL104). J Antimicrob Chemother 2012; 67:1354 - 8; http://dx.doi.org/10.1093/jac/dks079; PMID: 22441578

3. [3] Nguyen HT, Trujillo AA, Sheu TG, Levine M, Mishin VP, Shaw M, et al. Analysis of influenza viruses from patients clinically suspected of infection with an oseltamivir resistant virus during the 2009 pandemic in the United States. Antiviral Res 2012; 93:381 - 6; http://dx.doi.org/10.1016/j.antiviral.2012.01.006; PMID: 22330888

4. [4] Imtiaz T, Lee KK, Munro CA, Maccallum DM, Shankland GS, Johnson EM, et al. Echinocandin resistance due to simultaneous FKS mutation and increased cell wall chitin in a Candida albicans bloodstream isolate following brief exposure to caspofungin. J Med Microbiol 2012; 61:1330 - 4; http://dx.doi.org/10.1099/jmm.0.045047-0; PMID: 22653922

5. [5] Sader HS, Biedenbach DJ, Paukner S, Ivezic-Schoenfeld Z, Jones RN (2012). Antimicrobial activity of the investigational pleuromutilin compound BC-3781 tested against Gram-positive organisms commonly associated with acute bacterial skin and skin structure infections. Antimicrob Agents Chemother; 56(3) 1619-23. https://doi.org/10.1128/AAC.05789-11. PMID: 22232289